Tag Archives: treatment
The Concussion Health Summit, In Partnership with Nationwide Children’s Hospital, Announces Dr. Kevin Guskiewicz as Keynote Speaker
Concussion Health, in partnership with Nationwide Children’s Hospital, will host The Concussion Health Summit in Columbus, Ohio, at the Hyatt Regency Friday, July 28-Saturday, July 29, 2017.
This two day long program will encourage education and discussion – bringing together an influential array of experts, practitioners, and innovators from a range of specialties who will discuss the latest knowledge and technology regarding concussion management. By emphasizing the importance of a multi-disciplinary approach, the Summit aims to make the connection between prevention, baseline testing, time of injury, post-injury exam and the recovery process. The Program Planning Committee has assembled a faculty of renowned clinical experts to provide opportunities for approved continuing education sessions as well as special programming for concussion
survivors and caregivers. The Concussion Health Summit will also provide opportunities to network through social events and round table discussions.
“Hearing from the diverse panel of experts assembled will afford attendees an opportunity to expand their knowledge and skill base in caring for concussion patients,” said Mark A. Letendre, ATC, Co-Chair of The Concussion Health Summit and Director of Umpire Medical Services for Major League Baseball. “Allowing a hands-on approach as part of the Summit will take thoughts and information shared and turn them into actionable patient care trajectories.”
The Summit will be highlighted by Dr. Kevin Guskiewicz who will serve as Luncheon Keynote Speaker on Saturday, July 29th. Dr. Guskiewicz is a neuroscientist, nationally recognized expert and leading researcher in the field of sport-related concussions. He became dean of the College of Arts and Sciences at the University of North Carolina at Chapel Hill in January 2016.
Other highlights include but are not limited to:
- Nationwide Children’s Hospital Speaker –Thomas Pommering, DO, is Division Chief for Sports Medicine and Medical Director for Nationwide Children’s Sports Medicine. He is a Clinical Assistant Professor in the Department of Pediatrics and Family Medicine at The Ohio State University College of Medicine. “The Concussion Health Summit is a great opportunity for medical professionals to learn and begin the process of applying the latest concussion diagnosis and clinical treatment advances supported by vigorous research,” said Pommering. “On behalf of Nationwide Children’s Hospital and Nationwide Children’s Sports Medicine, we are pleased to partner with Concussion Health and offer continued education and discussion on this very important topic.”
- Baseline/Performance and Rehab/Progression Hands-On Workshops – These 30 minute hands-on workshops mimic clinical settings, providing interactive experiences with experts and attendees. Topics include: Train Above the Neck; Neck Strengthening; Lower Extremity Functional Testing; Vestibular; Vision; Exertion; Sport Specific Training.
- Cutting-Edge Topics – Treatment of Concussion Starting Day 2; Baseline Testing as a Comprehensive Injury Program; Correlation Between Mild Head Trauma in Elderly Falls and Repeated Visits to the Emergency Department; Treatment Program for PTSD; Latest Non-Traditional Adjunctive Brain Recovery Therapies; Sub-Concussive Head Injuries; Neuropsychological Testing.
- Continuing Education Credits – The Concussion Health Summit has been approved for 14 EBP Category hours/CEUs for Athletic Trainers and 14 continuing education credit hours for Physical Therapists and Occupational Therapists.
“Traumatic brain injury (TBI) has received notable attention in the literature over many years with a consensus that each individual presents uniquely and recovery requires an intra-disciplinary and customized approach,” said Bridgett Wallace, PT, DPT and Co-Chair of The Concussion Health Summit. “Yet, such ideas towards concussion (a type of TBI) has lagged in both research and clinical application. It is extremely exciting and promising to see experts from a variety of medical specialties sharing their knowledge on the evolving field of concussion management, especially the evolution of concussion as a treatable injury.”
Concussion Health and Nationwide Children’s Hospital would like to thank the following sponsor and exhibitors for their support of The 2017 Concussion Health Summit: Bertec, ImPACT Applications, Inc.; Micromedical Technologies, Inc.; Upledger Institute; Atlas Concussion Testing; Biodex; Cyrex Laboratories; Center for Pain & Stress Research; The IronNeck; BrainCheck; MedTrak VNG, Inc, and Natus; Shuttle Systems. Also, a very special thank you to the Columbus Clippers!
Visit the Concussion Health website at www.concussionhealth.com/the-concussion-health-summit for more information regarding speakers and topics. Registration for healthcare and educational professionals, as well as survivors and caregivers is now open: https://www.concussionhealth.com/register.html
A new product was introduced today that holds great promise for maintaining and improving the health of the brain.
What separates Peak Health’s Bran Shake product from anything else on the market is that it is comprehensive and the foundation of the product is science.
Its not cheap. But for a product that holds so much promise, it may be worth considering for those suffering the cumulative effects of concussion, or a single concussion.
“The world’s leading researchers in nutrition have identified specific nutrients that are important for promoting brain health,” said Dr. Stacey Bell, the company’s team leader in the research area and formerly on the faculty of the Harvard Medical School. “Yet, no one has ever combined these nutrients into a complete meal. This is what the Brain Shake has – everything your brain needs and nothing it does not.”
The Brain Shake, which can be purchased at https://peakhealth.shop/, or www.thebrainshake.com, contains 119 nutrients (Chocolate) that have been shown in scientific studies to improve memory, cognition, focus, performance, and sharpness and to protect the brain as we age.
“This is the first comprehensive food or drink being brought to market that I have seen intended to improve the performance of the brain, as well as protect our brain as we age,” said Dr. Fernando Gomez-Pinilla, a professor at the University of California, Los Angeles, as well as the leading authority on the role of nutrition and the brain with more than 150 papers published on that topic.
In a press release, the company noted that “The Brain Shake™ is a complete meal, containing an excellent source of protein, 25 vitamins and minerals, fiber and omega-3s. It also contains Peak Health’s proprietary BrainCare™ a proprietary blend of nutrients (https://peakhealth.shop/pages/health) that target memory, focus, cognition, performance and long-term brain health. The Brain Shake has no artificial colors, flavors, or preservatives. It is also GMO-free, gluten-free, and contains no added sugar.
“Peak Health believes in supporting independent nutritional research and is currently funding four major studies with leading research universities concerning the importance of nutrient-rich foods and brain health, satiety, obesity/diet, and children development.”
Dr. Bell added: “We built the Brain ShakeTM based on the most accepted, peer-reviewed research studies on brain health and nutrition. To continue to expand our understanding, we are launching a major clinical study with a world-renowned research university to further demonstrate the effect the Brain Shake has on brain health.”
On December 13, 2016, the DEA issued its Final Rule, “Establishment of New Drug Code for Marihuana Extract,” which could ultimately impact the development of drug treatments related to cannabinoids that are used to treat the symptoms of concussion.
Robert Hoban, a cannabis, cannabinoid and hemp lawyer and expert as well as an adjunct professor of law at The University of Denver, states the DOJ and DEA cannot unilaterally make law and schedule controlled substances, thus causing this Final Rule to exceed the DEA’s authority. Instead, such actions require an act of Congress.
As is the case here, the DEA is an agency that has previously sought to exceed its authority contrary to applicable law. It is anticipated that this “final ruling” and determination will be challenged both in court and administratively across the country. With 28 states that already have medical cannabis laws on the books, 8 states passing adult use laws in the November election, and numerous other states enacting industrial hemp legislation, the industry is up for the challenge of litigation against any government agency that operates contrary to prevailing law and enforcement policies.
The DEA’s Final Rule seeks to broadly expand and override existing definitions of controlled substances by newly creating a “Marihuana Extract” classification. The effect of this Final Rule appears to be incorporation of any and all cannabinoids from the Cannabis plant as a Schedule 1 controlled substance, despite the fact that many such cannabinoids are naturally occurring derived from non-“marihuana” portions of the plant or or from entirely different plants altogether. Problematically, the Final Rule fails to acknowledge there exist certain parts of the plant, and certain types of the plant — namely, industrial hemp — which cannot and should not be treated as a “Marihuana Extract.” Notably, the DEA has sought to unilaterally create laws before, and has lost, when challenged.
Hoban surmises, “The feeling is that this is an action beyond the DEA’s authority and we believe this is unlawful and we are taking a course of action for our clients. This Final Rule serves to threaten hundreds, if not thousands, of growing businesses, with massive economic and industry expansion opportunities, all of which conduct lawful business in reliance upon the Federal Government also acting pursuant to law, and as ordered by the Ninth Circuit in 2003 and 2004. We will see the Federal Government in court.”